Content Reviewed By

Reviewed by a board-certified physician (Medical) · Reviewed by a licensed attorney specializing in mass tort litigation (Legal)

FDA Regulatory History of Artificial Food Dyes: A Timeline

Published March 2026 · 10 min read

Medically reviewed by licensed healthcare professionals · Legally reviewed by mass tort litigation specialists · Last updated:

The FDA's regulation of artificial food dyes spans more than a century and reflects the tension between industry interests, evolving science, and public health advocacy. Understanding this history helps explain why dyes with known risk signals remained on American shelves long after other countries restricted them — and why that gap matters in litigation.

Origins: The Pure Food and Drug Act Era

Federal regulation of food dyes began with the Pure Food and Drug Act of 1906, which gave the government authority to regulate adulteration of food and drugs. At that time, many food colorants were derived from coal tar — a byproduct of coal processing — and some were demonstrably toxic. Early regulation focused on removing the most obviously dangerous colorants and certifying those that met basic safety thresholds.

The Food, Drug, and Cosmetic Act of 1938 strengthened the framework, creating a certification system for synthetic food dyes. Manufacturers had to submit batches of dye to the FDA for testing before use, and only certified batches could be legally used in food. This system — batch certification — continued for decades and created a formal regulatory relationship between the FDA and synthetic dye manufacturers that shaped how safety concerns were handled going forward.

The Delaney Clause and Its Selective Application

A significant moment in food dye regulatory history came with the 1958 Food Additives Amendment, which included the Delaney Clause. The Delaney Clause prohibits FDA approval of any food additive shown to cause cancer in humans or animals. This provision, intended to establish a zero-tolerance standard for carcinogens, would later become central to the Red Dye 3 story.

Red Dye 3 — also known as erythrosine — was found in the 1980s to cause thyroid tumors in male rats at high doses. Under a strict reading of the Delaney Clause, this finding should have triggered immediate revocation of approval. The FDA did revoke Red Dye 3's approval for cosmetics and externally applied drugs in 1990, explicitly citing the Delaney Clause. But the agency left Red Dye 3's approval for ingested food and ingested drugs in place — a legally inconsistent position that advocacy groups challenged for decades.

That inconsistency persisted for 35 years. Red Dye 3 continued to appear in common foods — including maraschino cherries, candy, and certain processed foods — until the FDA finally revoked its food authorization in January 2025. The three-and-a-half-decade delay between identifying the cancer risk and completing the ban is a recurring reference point in litigation arguments about regulatory capture and industry influence on safety timelines.

The 2011 Advisory Committee and Its Outcome

Following the 2007 Southampton study's findings on synthetic dyes and childhood hyperactivity, the FDA convened a Food Advisory Committee in March 2011 to review the evidence. The committee included scientists, medical professionals, and consumer representatives. After two days of testimony and deliberation, the committee voted that the evidence did not support requiring warning labels on products containing synthetic food dyes — though multiple members acknowledged the association between dyes and behavioral effects in sensitive children.

The outcome was widely criticized by children's health advocates, who argued that the FDA applied a higher evidentiary standard for action than Europe had used. The Center for Science in the Public Interest, which had petitioned the FDA to require warning labels or ban the dyes outright, noted that the committee's decision effectively required proof of harm in every exposed child before requiring disclosure to any parent.

The 2011 committee review is significant in the litigation record because it represents an explicit moment when the FDA acknowledged the behavioral research, convened expert review, and chose not to act on it. Manufacturers were aware of that process and its outcome. Arguments that they lacked notice of the potential behavioral risks after 2011 face the documented fact that the FDA convened an expert committee specifically to examine those risks.

State-Level Action Where Federal Policy Stalled

When federal regulation did not move, states began acting independently. California's Food Safety Act, signed in 2023, banned several food additives including Red Dye 3, brominated vegetable oil, potassium bromate, and propylparaben. California was the first state to enact such thorough food additive restrictions, and its action accelerated the federal timeline — the FDA's January 2025 Red Dye 3 ban came in part because California's state ban would have created a fragmented regulatory environment.

Other states introduced legislation targeting synthetic food dyes, and West Virginia enacted a ban on several dyes in school foods in early 2025. The wave of state legislative activity in 2023 through 2025 represents a significant shift in the political environment around food dye regulation, and it created a documented record of government bodies treating these additives as serious enough to restrict — a record that is directly relevant to litigation arguments.

The 2025 Red Dye 3 Ban and What It Means

The FDA's January 2025 revocation of Red Dye 3's authorization for food and ingested drugs marked the completion of a process that began with the Delaney Clause finding in the 1980s. Manufacturers were given a compliance deadline — January 2027 for most food products and January 2028 for ingested drugs — to reformulate and remove Red Dye 3 from their products.

For litigation purposes, the ban itself is significant in two ways. First, it confirms that Red Dye 3 did not meet federal safety standards, lending weight to the argument that it should not have remained in food for decades after the cancer risk was identified. Second, it establishes a before-and-after moment: consumers who were harmed during the period the dye remained approved despite known risks may have viable claims even though the product was technically legal at the time of sale. Regulatory approval does not foreclose product liability claims under most state tort law frameworks.

What the Regulatory Record Means for Consumers

The FDA's history with artificial food dyes illustrates a pattern: safety signals emerge from independent research, regulatory response is slow, and consumers bear the risk during the gap between signal and action. That gap — sometimes measured in years, sometimes in decades — is precisely where legal claims are situated.

For families considering whether regulatory history supports their situation, the key questions are when the products they consumed were sold, what the FDA and manufacturers knew at that time, and whether adequate disclosures were made. A free case review can help map those questions to your specific circumstances and timeline.

Related Pages on This Site

Does the Regulatory History Apply to Your Situation?

Understanding what the FDA knew and when is central to many food dye claims. A free case review can help you connect that history to your family's specific circumstances.

Request a Free Case Review →
As Referenced In
Were you affected by Red Dye 3? You may qualify for compensation. Check Eligibility →